Research Solutions Inc Stock Price, News & Analysis

Research Solutions, Inc. (NASDAQ: RSSS) has announced a transition in its executive management. Effective March 29, 2021, Peter Derycz becomes Executive Chairman, while Roy W. Olivier takes on the role of Interim President and CEO as the board searches for a permanent leader. Derycz, founder of the company, will focus on strategy and product development. Olivier aims to leverage his experience to drive growth, particularly through M&A opportunities. This change is part of the company's effort to enhance its cloud-based SaaS offerings and increase shareholder value.

Research Solutions, Inc. (NASDAQ: RSSS) will participate in the Virtual 33rd Annual ROTH Conference from March 15-17, 2021. CEO Peter Dercyz and CFO Alan Urban will hold virtual one-on-one meetings at the event. The company specializes in cloud-based workflow solutions for R&D organizations, streamlining access to scientific research through its platform, Article Galaxy. With over 70% of leading pharmaceutical companies and universities relying on its services, it offers both individual and enterprise plans with 24/7 customer support.

Research Solutions, Inc. (NASDAQ: RSSS) reported its fiscal 2021 second-quarter results, highlighting a 29% increase in platform revenue to $1.2 million and a 35% rise in annual recurring revenue to $5 million. Despite a 1% decline in total revenue to $7.4 million, the net loss improved by 56% to $(261,000), with loss per share at $(0.01). Adjusted EBITDA rose to $161,000, a significant improvement of $345,000. The company continues to transition towards higher-margin SMB customers, impacting transaction revenue, which decreased by 5%.

Research Solutions, Inc. (NASDAQ: RSSS) will announce its financial results for the fiscal 2021 second quarter, ending December 31, 2020, during a conference call on February 11, 2021, at 5:00 p.m. ET. The press release detailing the financial results will be issued after market close before the call. CEO Peter Derycz and CFO Alan Urban will host the call, providing insights and engaging in a Q&A session. A replay will be accessible until March 4, 2021, post the initial call.

Research Solutions, Inc. (NASDAQ: RSSS) reported a modest 2% increase in total revenue to $7.7 million for the first quarter of fiscal 2021. The platform revenue surged 33% to $1.1 million, with annual recurring revenue rising 35% to $4.7 million. Gross margins improved to 31.6%, up 110 basis points year-over-year. The company recorded a net income of $15,000, a significant turnaround from a loss of $81,000 in the previous year. Adjusted EBITDA also saw a remarkable improvement, up 369% to $167,000.

Research Solutions, Inc. (NASDAQ: RSSS) will participate in the Three Part Advisors' virtual Southwest IDEAS Conference on November 18, 2020. The presentation will be webcast, available at 7:00 am CT, and can be accessed via the conference portal at www.IDEASconferences.com. Qualified investors can arrange meetings with management through Steven Hooser at shooser@threepa.com. Research Solutions specializes in cloud-based workflow solutions for R&D, with over 70% of leading pharmaceutical companies utilizing its Article Galaxy platform.

Research Solutions, Inc. (NASDAQ: RSSS) will announce its financial results for the first quarter of fiscal 2021, ending September 30, 2020, on November 12, 2020. The company’s President and CEO, Peter Derycz, along with CFO Alan Urban, will host a conference call at 5:00 p.m. ET to discuss these results, followed by a Q&A session. A press release will precede the call, and investors can access a replay of the call afterwards until December 3, 2020.

Research Solutions (NASDAQ: RSSS) has partnered with BIO Business Solutions to enhance access to scholarly literature for life sciences companies. This collaboration aims to provide members with significant savings and streamlined access to scientific content through Article Galaxy. Benefits include a 15% discount on subscriptions and a 20% reduction in article spending. More than 4,500 member organizations currently save over $511 million annually through BIO's cost-saving program, supporting innovation in biotechnology.

Research Solutions, Inc. (NASDAQ: RSSS) reported a 5.5% increase in fourth-quarter revenue to $7.9 million and a 7.9% rise in full-year revenue to $31.1 million for FY2020. Platform revenue surged 33% to $1.1 million in Q4 and 38% to $3.9 million for the year, with annual recurring revenue reaching $4.4 million. Gross margins improved to 31.8% in Q4 and 31.0% for the year. Adjusted EBITDA showed significant growth, increasing to $146,000 quarterly and $143,000 annually. Cash reserves rose to $9.3 million. The company successfully uplisted to NASDAQ on March 23, 2020.